You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trametinib

Showing 26 - 50 of 253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)

Completed
  • Malignant Neoplasms of Digestive Organs
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 23, 2022

Pancreatic Cancer Trial in Shanghai (Cyberknife plus Pembrolizumab and Trametinib, Cyberknife plus Gemcitabine)

Completed
Has Results
  • Pancreatic Cancer
  • Cyberknife plus Pembrolizumab and Trametinib
  • Cyberknife plus Gemcitabine
  • Shanghai, Shanghai, China
    Changhai hospital
Feb 28, 2022

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Trametinib
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Dec 13, 2022

Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Recruiting
  • Malignant Melanoma
  • dabrafenib + trametinib
  • Coimbra, Center, Portugal
  • +5 more
Jun 9, 2022

Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,

Recruiting
  • Thyroid Gland Anaplastic Carcinoma
  • Thyroid Gland Squamous Cell Carcinoma
  • Conventional Surgery
  • +5 more
  • Stanford, California
  • +5 more
Jan 26, 2023

Solid Tumors, Melanoma, NSCLC Trial in France, Spain, United States (CFT1946, Trametinib)

Recruiting
  • Solid Tumors
  • +4 more
  • Boston, Massachusetts
  • +9 more
Dec 19, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)

Active, not recruiting
  • Pancreatic Cancer
  • Adenocarcinoma
  • Hamilton, Ontario, Canada
  • +3 more
May 12, 2022

Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

Available
  • Melanoma
  • Adjuvant
  • Dabrafenib and Trametinib
  • +2 more
  • (no location specified)
Mar 1, 2022

Solid Tumors, KRAS Mutation; SOS1 Trial in Germany, Netherlands, United States (BI 1701963, Trametinib)

Active, not recruiting
  • Solid Tumors, KRAS Mutation; SOS1
  • BI 1701963
  • Trametinib
  • Boston, Massachusetts
  • +7 more
Aug 22, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Non Small Cell Lung Cancer, KRAS Gene Mutation Trial in United States (Trametinib 0.5 mg, Trametinib 1 MG, Trametinib 1.5 MG)

Completed
  • Non Small Cell Lung Cancer
  • KRAS Gene Mutation
  • Trametinib 0.5 mg
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 7, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Venous Malformation, Arterial Disease Trial in Palo Alto (Trametinib tablet)

Recruiting
  • Venous Malformation
  • Arterial Disease
  • Trametinib tablet
  • Palo Alto, California
    Pediatric Dermatology Clinic at Stanford Children's Hospital
Feb 25, 2022

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Trametinib
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +1 more
Nov 8, 2022

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Solid Tumors Trial in Worldwide (Trametinib, Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol))

Completed
  • Solid Tumors
  • Trametinib
  • Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)
  • Detroit, Michigan
  • +6 more
Feb 7, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 1, 2022

NSCLC Trial in China (Dabrafenib, Trametinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Harbin, Heilongjiang, China
  • +9 more
Jun 13, 2022

Dabrafenib in Combination With Trametinib as Adjuvant Treatment

Recruiting
  • Melanoma
  • Zhengzhou, Henan, China
  • +6 more
Mar 17, 2022

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022